# DESCRIPTION

## FIELD OF THE INVENTION

- relate to allergic diseases and protein engineering

## BACKGROUND OF THE INVENTION

- describe allergic diseases and horse allergy
- discuss current approaches to allergen modification and immunotherapy

## SUMMARY OF THE INVENTION

- introduce recombinant hypoallergenic Equ c 1 polypeptides for immunotherapy

## DETAILED DESCRIPTION OF THE INVENTION

- define hypoallergenic polypeptide variants
- motivate mutations for reduced IgE antibody production
- describe preferred amino acid substitutions
- outline characteristics of recombinant hypoallergenic Equ c 1 polypeptide
- discuss pharmaceutical compositions and administration routes
- describe method of producing recombinant hypoallergenic Equ c 1 polypeptide

### EXPERIMENTAL SECTION

- design Equ c 1 mutations
- produce recombinant Equ c 1 wt and mutants
- purify recombinant Equ c 1 polypeptides
- analyze recombinant Equ c 1 by mass spectrometry
- analyze IgE binding and biological activity

